BMS, Sanofi Pushed Docs To Overprescribe Plavix, Suit Says

Law360, New York (July 2, 2013, 5:45 PM EDT) -- Bristol-Myers Squibb Co. and Sanofi SA faced more fallout Monday from long-simmering reports that their blood-thinner Plavix carries internal injury risks as more than three dozen users and their survivors claimed in Illinois court that the companies pushed physicians for years to overprescribe the drug.

Brought on behalf of patients who were first prescribed Plavix as late as August 2011 and as early as 1997, the suit claims that the joint developers of Plavix ignored clinical evidence that the drug was no more effective than aspirin...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.